The Global Neuroscience Market and Its Future Prospects

Brain disorders, the leading cause of disability worldwide, have long needed effective treatment. With advancements beyond neurology in other areas of medicine, there is now hope for new treatments to alleviate the suffering of millions of patients worldwide. Deloitte’s comprehensive study of the global neurology (GNM) market provides insight in terms of market segmentation and growth factors.

Impact of brain diseases

Brain diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and ALS, place a significant burden on societies worldwide. Current treatments offer improvements, thus requiring additional investments to raise the standard of care. Barriers to treatment stem from a lack of understanding of the biological basis of brain diseases, inadequate use of commonly used medications, and a lack of early diagnostic tools.

Conclusions

GNM, valued at $612 billion by 2022, is expected to reach $721 billion by 2026, growing at a CAGR of 4.2 percent. More than 75% of the market value comes from North America and Europe, while emerging markets, particularly in Africa, offer untapped growth potential. The neuroscience research market is driven by medical imaging and next-generation sequencing technologies, while medical interventions dominate the pharmaceutical market, and emerging as a market non-pharmaceutical, especially behavioral therapy services, will increase, especially in digital health.

Investment Opportunities

Deloitte’s research highlights potential investment opportunities in GNM segments, taking into account regional differences and local dynamics. High-value segments imply lower growth rates, while high-value segments hold the promise of higher growth rates. Private equity, investment, and corporate M&A firms can adjust their investment strategies based on trends and forecasts in earnings in different segments.

The Future of Neuroscience

With energy and innovation pouring into neuroscience, breakthrough treatment possibilities are readily available. Investing in the global neuroscience market can not only generate significant returns but also contribute to the long-term economic resilience of societies. As we continue to focus on brain health in this ‘brain economy,’ it is important to prioritize mental wellbeing and drive advances in neuroscience to improve the lives of patients worldwide.